NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL) announced today that the Company is scheduled to present at The Merrill Lynch Eighteenth Annual Global Pharmaceutical,
For more information, please visit
http://home.businesswire.com/portal/site[...]=en&ndmConfigId=1001385&vnsId=